Guanghui Li
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Preclinical and phase I randomized study of a potent inhalable nanobody targeting TSLP for the treatment of airway inflammation.
Journal: The Journal of allergy and clinical immunology
Published: February 13, 2025
Efficient development of nanobody-based affinity chromatography for AAV8 purification.
Journal: Protein expression and purification
Published: September 30, 2024
A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
Journal: Journal of nanobiotechnology
Published: February 12, 2024
A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma.
Journal: The Journal of allergy and clinical immunology
Published: November 20, 2023
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer.
Journal: Journal of nanobiotechnology
Published: August 24, 2023
Precessing jet nozzle connecting to a spinning black hole in M87.
Journal: Nature
Published: February 24, 2023
Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
Journal: Respiratory research
Published: August 30, 2022
Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike Protein.
Journal: Cells
Published: August 16, 2022
Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice.
Journal: Research (Washington, D.C.)
Published: March 03, 2022
Nanobody-based label-free photoelectrochemical immunoassay for highly sensitive detection of SARS-CoV-2 spike protein.
Journal: Analytica chimica acta
Published: February 22, 2022
A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade.
Journal: Biochemical and biophysical research communications
Published: July 12, 2020
Last Updated: 09/26/2026